how to transition from tirzepatide to semaglutide Transitioning Treatments: What Expect When Changing Why You Might Tolerate One

Growth hormone response declines with age, so baseline GH status influences efficacy

And guessing with a compound as potent as tirzepatide, which acts on both GLP-1 and GIP receptors simultaneously, is a risk nobody should take

Please call the office to schedule a consultation with Dr

When it comes to medical weight loss , three groundbreaking treatments Semaglutide, Tirzepatide, and Retatrutide are making waves

When documenting adverse effects of Mounjaro, clinicians should first code the manifestation (the clinical presentation or symptom) followed by an external cause code from the Y40-Y59 range to indicate that the manifestation was caused by a medication in therapeutic use

The medication acts as a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors